AGP Picks
View all

Military Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Military Press Releases.

Press releases published on November 9, 2026

ABIS to Highlight 2K Injection Molds at PLASTIMAGEN MEXICO 2026
Airpower Foundation Honors Veterans Through Stories of Service, Sacrifice, and a Mission That Continues
GECCO Showcases Secure and Sovereign Edge AI Platform at Web Summit 2026 Lisbon
Blumind Launches BM110 Evaluation Kit, Putting Ultra-Low-Power Analog AI Compute on the Customer’s Bench
SPEE3D kicks off 50-factory Asia Pacific advanced manufacturing network
OrthoPediatrics Announces Full Commercial Launch of VerteGlide® Spinal Growth Guidance System
NeurAxis Reports Record Third Quarter 2026 Financial Results Driven by 150% Year Over Year Revenue Growth
Notice of Extraordinary General Meeting of Shareholders of Kaspi.kz
Kamada Reports Record-High First Nine Months 2026 Financial Results; Increases 2026 Annual Guidance and Projects Double-Digit Growth in Revenues and Profitability in 2027
Immunocore to present at upcoming investor conferences
Silexion Therapeutics Announces 1-for-24 Reverse Share Split
Octave introduces Attune Facilities, bringing AI-powered facilities management and spatial intelligence to complex multi-site operations
TRIDENT post-hoc analysis of low-dose triple combination therapy by kidney function in people with prior intracerebral hemorrhage presented at American Heart Association’s Scientific Sessions 2026
GT Biopharma Oral Presentation at the SITC 2026 Annual Meeting
NovaBridge Biosciences to Participate in Upcoming Investor Conferences
Aura Biosciences Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Aquestive Therapeutics to Present at the Jefferies Global Healthcare Conference
Zenas BioPharma to Present at the Jefferies London Global Healthcare Conference
PyroGenesis Announces Titanium Powder Contract with Global Aerospace Leader
Adagene Announces Completion of Enrollment in Randomized Dose Optimization Phase 2 Trial of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Military Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.